Clinical Trial: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer

Share this article:
Clinical Trial: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer

Sponsor and Collaborators

Children's Oncology Group
National Cancer Institute (NCI)

Principal Investigator
Howard M. Katzenstein, MD AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus

ClinicalTrials.gov Identifier
NCT00980460
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Liver Cancer Clinical Trials

Clinical Trial: Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating ...

Clinical Trial focusing on advanced liver cancer treatment. Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Clinical Trials: Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That ...

Clinical trial focusing on chemoembolization versus radioembolization in liver cancer patients. Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Clinical Trial: Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating ...

Clinical trial focusing on transarterial chemoembolization. Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer